As a tumor suppressor, Arid1a is associated with the development, survival, and progression of cancer cells, and its dysfunction may be key tumorigenic events in ovarian, endometrial, gastric, and breast cancers (Zang et al., 2012; Takeda et al., 2016). This evidence concerns the gene ARID1A and neoplasm.